Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1
Nico Janssen, Rémy Nyga, Lore Vanderbeke, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 11, pp. 2892-2898
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Tackling the emerging threat of antifungal resistance to human health
Matthew C. Fisher, Ana Alastruey‐Izquierdo, Judith Berman, et al.
Nature Reviews Microbiology (2022) Vol. 20, Iss. 9, pp. 557-571
Open Access | Times Cited: 655
COVID-19-associated fungal infections
Martin Hoenigl, Danila Seidel, Rosanne Sprute, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1127-1140
Open Access | Times Cited: 327
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
Simon Feys, Samuel M. Gonçalves, Mona Khan, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1147-1159
Open Access | Times Cited: 69
Fungal Drug Response and Antimicrobial Resistance
Paloma Osset-Trénor, Amparo Pascual‐Ahuir, Markus Proft
Journal of Fungi (2023) Vol. 9, Iss. 5, pp. 565-565
Open Access | Times Cited: 43
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Matteo Bassetti, Daniele Roberto Giacobbe, Christina Agvald‐Öhman, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 4, pp. 502-515
Open Access | Times Cited: 39
Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis
Francesca Gioia, Laura N. Walti, Ani Orchanian‐Cheff, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 3, pp. 207-216
Closed Access | Times Cited: 20
A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
Simon Feys, Maria Panagiota Almyroudi, Reinout Braspenning, et al.
Journal of Fungi (2021) Vol. 7, Iss. 12, pp. 1067-1067
Open Access | Times Cited: 77
Invasive pulmonary aspergillosis among intubated patients with SARS-CoV-2 or influenza pneumonia: a European multicenter comparative cohort study
Anahita Rouzé, Elise Lemaître, Ignacio Martín‐Loeches, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 57
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
Rasmus Leistner, Lisa Schroeter, Thomas C. Adam, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 56
Increased Deaths From Fungal Infections During the Coronavirus Disease 2019 Pandemic—National Vital Statistics System, United States, January 2020–December 2021
Jeremy A.W. Gold, Farida B. Ahmad, Jodi A. Cisewski, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e255-e262
Open Access | Times Cited: 48
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
Matthias Egger, Linda Bussini, Martin Hoenigl, et al.
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 390-390
Open Access | Times Cited: 40
Immunity to fungi in the lung
Lena J. Heung, Darin L. Wiesner, Keyi Wang, et al.
Seminars in Immunology (2023) Vol. 66, pp. 101728-101728
Open Access | Times Cited: 36
Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
Martin Hoenigl, Matthias Egger, Jessica S. Price, et al.
Journal of Clinical Microbiology (2023) Vol. 61, Iss. 3
Open Access | Times Cited: 34
High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation
Simon Feys, Katrien Lagrou, Hanne Moon Lauwers, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 361-370
Open Access | Times Cited: 23
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
Simon Feys, Agostinho Carvalho, Cornelius J. Clancy, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 728-742
Closed Access | Times Cited: 12
A B1a–natural IgG–neutrophil axis is impaired in viral- and steroid-associated aspergillosis
Nicole Sarden, Sarthak Sinha, Kyle Potts, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 674
Closed Access | Times Cited: 30
Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy
Rebecca van Grootveld, Martha T. van der Beek, Nico Janssen, et al.
Journal of Critical Care (2023) Vol. 76, pp. 154272-154272
Open Access | Times Cited: 16
Point-of-care testing for viral-associated pulmonary aspergillosis
Robina Aerts, Brice Autier, Maximilian Gornicec, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 24, Iss. 3, pp. 231-243
Open Access | Times Cited: 16
COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study
William Hurt, Jonathan Youngs, Jonathan Ball, et al.
Thorax (2023) Vol. 79, Iss. 1, pp. 75-82
Open Access | Times Cited: 15
Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment
Jannes Heylen, Yuri Vanbiervliet, Johan Maertens, et al.
Seminars in Respiratory and Critical Care Medicine (2024) Vol. 45, Iss. 01, pp. 069-087
Open Access | Times Cited: 6
Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis
Samuel M. Gonçalves, Inês M. Pereira, Simon Feys, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants
Pierre Bay, Étienne Audureau, Sébastien Préau, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Epidemiology of Coronavirus Disease 2019-Associated Fungal Infections in the Intensive Care Unit: A Single-Center Retrospective Study
Jessica S Little, Gerald McGwin, Lisa A Tushla, et al.
Mycopathologia (2025) Vol. 190, Iss. 1
Closed Access
Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome
Lenn Maessen, Leonoor S. Boers, Jannes Heylen, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240153-240153
Open Access
Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Severe Cases: A Single-Center Study from Japan
Kengo Kawamoto, Waki Imoto, Yoshihiro Kimura, et al.
Journal of Infection and Chemotherapy (2025), pp. 102676-102676
Closed Access
Page 1 - Next Page

Scroll to top